Coats P, Johnston F, MacDonald J, McMurray J J, Hillier C
School of Biological and Biomedical Sciences, Glasgow Caledonian University, Cowcaddens Road, Scotland, Glasgow, UK.
Cardiovasc Res. 2001 Mar;49(4):828-37. doi: 10.1016/s0008-6363(00)00314-x.
In this study we have examined for the first time the signal transduction mechanisms involved in the generation of pressure-dependent myogenic tone in human small resistance arteries from the subcutaneous vascular bed.
Myogenic responses and the subcellular mechanisms involved in the generation of this response were studied on a pressure myograph.
Human subcutaneous resistance arteries constricted 14.1+/-1.1% in response to an increases in intraluminal pressure from 40 to 80 mmHg and a further 3.5+/-1.7% in response to the 80-120-mmHg pressure step. Ca(2+) depletion or nifedipine abolished this response, whereas BAY K 8644 increased this response to 20.6+/-2.1% (P<0.05, response vs. control). The phospholipase C inhibitor U-73122 reduced the myogenic response to 2.5+/-1.0% at 80 mmHg (P<0.01, response vs. control) and abolished it at 120 mmHg. Diacylglycerol lipase inhibition with RHC-80267 abolished all myogenic responses to pressure. The protein kinase C (PKC) activator phorbol 12,13-dibutyrate increased the maximal myogenic response to 20.9+/-1.8% (P<0.05, response vs. control), whereas the PKC inhibitor calphostin C abolished myogenic responses. These data show that the generation of pressure-dependent myogenic tone in human subcutaneous arteries is dependent on Ca(2+) influx via voltage operated Ca(2+) channels (VOCCs) and a concomitant requirement for the activation of phospholipase C (PLC), diacylglycerol, and PKC.
在本研究中,我们首次研究了皮下血管床人小阻力动脉中压力依赖性肌源性张力产生所涉及的信号转导机制。
在压力肌动描记仪上研究肌源性反应以及产生该反应所涉及的亚细胞机制。
随着管腔内压力从40 mmHg升高至80 mmHg,人皮下阻力动脉收缩14.1±1.1%,压力进一步从80 mmHg升至120 mmHg时,动脉再收缩3.5±1.7%。Ca(2+)耗竭或硝苯地平可消除该反应,而BAY K 8644可使该反应增强至20.6±2.1%(P<0.05,反应与对照相比)。磷脂酶C抑制剂U-73122在80 mmHg时可将肌源性反应降低至2.5±1.0%(P<0.01,反应与对照相比),在120 mmHg时可消除该反应。用RHC-80267抑制二酰基甘油脂肪酶可消除所有压力依赖性肌源性反应。蛋白激酶C(PKC)激活剂佛波醇12,13-二丁酸酯可使最大肌源性反应增强至20.9±1.8%(P<0.05,反应与对照相比),而PKC抑制剂钙泊三醇可消除肌源性反应。这些数据表明,人皮下动脉中压力依赖性肌源性张力的产生依赖于通过电压门控Ca(2+)通道(VOCCs)的Ca(2+)内流以及对磷脂酶C(PLC)、二酰基甘油和PKC激活的伴随需求。